Company · CIK 0001264587
STEMLINE THERAPEUTICS INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/ASTEMLINE THERAPEUTICS INC0001580642-21-000680 · 42.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-20-071766 · 136.9 KBSEC(opens sec.gov)
- SC 13DSTEMLINE THERAPEUTICS INC0001104659-20-060709 · 118.9 KBSEC(opens sec.gov)
- 10-QQuarterly update0001104659-20-059604 · 6.8 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-20-055854 · 1.3 MBSEC(opens sec.gov)
- 10-KAnnual report0001104659-20-034154 · 9.4 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-20-033250 · 110.8 KBSEC(opens sec.gov)
- SC 13G/ASTEMLINE THERAPEUTICS INC0001104659-20-022143 · 53.6 KBSEC(opens sec.gov)
- SC 13GSTEMLINE THERAPEUTICS INC0001104659-20-020854 · 72.6 KBSEC(opens sec.gov)
- SC 13G/ASTEMLINE THERAPEUTICS INC0000902664-20-000952 · 100.5 KBSEC(opens sec.gov)
Insiders
- BENTSUR RONDirector
- Bergstein IvanDirector, Chief Executive Officer
- BUCHI J KEVINDirector
- Cline Darren SDirector
- DOBMEIER ERICDirector
- Forman Alan SDirector
- Francomano RobertChief Commercial Officer
- Gionco DavidChief Accounting Officer
- HALL STEPHEN PChief Accounting Officer
- Hoberman KennethChief Operating Officer
Tickers
No tickers on record.
Addresses
business
750 LEXINGTON AVENUE ELEVENTH FLOOR
NEW YORK, NY, 10022
mailing
750 LEXINGTON AVENUE
NEW YORK, NY, 10022
Same industry